Skip to main content
Top
Published in: Abdominal Radiology 8/2017

01-08-2017

Post-Whipple imaging in patients with pancreatic ductal adenocarcinoma: association with overall survival: a multivariate analysis

Authors: Azadeh Elmi, Janet Murphy, Sandeep Hedgire, Shaunagh McDermott, Seyed-Mahdi Abtahi, Elkan Halpern, Carlos Fernandez-del Castillo, Mukesh Harisinghani

Published in: Abdominal Radiology | Issue 8/2017

Login to get access

Abstract

Purpose

To compare the survival outcomes in patients with pancreatic ductal adenocarcinoma (PDAC) who had regular imaging surveillance with those who had clinical follow-up after Whipple.

Method

We identified 229 patients, who underwent Whipple for resection of PDAC from 2005 to 2011, and had regular postoperative clinical follow-up at our hospital. Patients were retrospectively selected for two follow-up groups: imaging surveillance (IS) defined as routine imaging at scheduled intervals, vs. clinical (C) defined as imaging triggered by either change in clinical status or change in CA19-9. Follow-up was obtained through the hospital and Cancer Data Registry records. Survival was calculated from the date of surgery to death or last follow-up, with data censored as of March 13, 2013. Kaplan–Meier survival curves were compared using the log-rank test, and Cox regression models were used for multivariate analysis.

Results

Patients were followed for a mean period of 24.35 ± 2.56 months. IS-group underwent significantly more imaging (4.41 vs. 2.08 scans/year). The most frequent imaging was CT of chest and abdomen at 3–4 month interval. Univariate associations with overall survival were detected with post-Whipple ECOG status, T-stage, N-stage, tumor grade, surgical margin, recurrence, and IS. In multivariate analysis, grade, ECOG status, and recurrence were independent predictors of survival. Also, our predictor of interest, IS, was highly associated with longer survival in multivariate modeling (median overall survival, 30.4±3.85 (IS-group) vs. 17.1 ± 2.42 (C-groups) month, log-rank p = 0.002).

Conclusion

Routine imaging surveillance was associated with prolonged overall survival post-Whipple in a multivariate model. This is a hypothesis-generating finding that should be studied prospectively and could ultimately impact surveillance guidelines.
Literature
2.
go back to reference Ferrone CR, Brennan MF, Gonen M, et al. (2008) Pancreatic adenocarcinoma: the actual 5-year survivors. J Gastrointest Surg Off J Soc Surg Aliment Tract 12:701–706CrossRef Ferrone CR, Brennan MF, Gonen M, et al. (2008) Pancreatic adenocarcinoma: the actual 5-year survivors. J Gastrointest Surg Off J Soc Surg Aliment Tract 12:701–706CrossRef
3.
4.
go back to reference Hoem D, Viste A (2012) Improving survival following surgery for pancreatic ductal adenocarcinoma–a ten-year experience. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 38:245–251 Hoem D, Viste A (2012) Improving survival following surgery for pancreatic ductal adenocarcinoma–a ten-year experience. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 38:245–251
5.
go back to reference Ferrone CR, Pieretti-Vanmarcke R, Bloom JP, et al. (2012) Pancreatic ductal adenocarcinoma: long-term survival does not equal cure. Surgery 152:S43–S49CrossRefPubMedPubMedCentral Ferrone CR, Pieretti-Vanmarcke R, Bloom JP, et al. (2012) Pancreatic ductal adenocarcinoma: long-term survival does not equal cure. Surgery 152:S43–S49CrossRefPubMedPubMedCentral
6.
go back to reference Sener SF, Fremgen A, Menck HR, Winchester DP (1999) Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. J Am Coll Surg 189:1–7CrossRefPubMed Sener SF, Fremgen A, Menck HR, Winchester DP (1999) Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. J Am Coll Surg 189:1–7CrossRefPubMed
7.
go back to reference Oettle H, Post S, Neuhaus P, et al. (2007) Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297:267–277CrossRefPubMed Oettle H, Post S, Neuhaus P, et al. (2007) Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297:267–277CrossRefPubMed
8.
go back to reference Lim JE, Chien MW, Earle CC (2003) Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg 237:74–85CrossRefPubMedPubMedCentral Lim JE, Chien MW, Earle CC (2003) Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg 237:74–85CrossRefPubMedPubMedCentral
9.
go back to reference Riediger H, Keck T, Wellner U, et al. (2009) The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer. J Gastrointest Surg Off J Soc Surg Aliment Tract 13:1337–1344CrossRef Riediger H, Keck T, Wellner U, et al. (2009) The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer. J Gastrointest Surg Off J Soc Surg Aliment Tract 13:1337–1344CrossRef
10.
go back to reference Van den Broeck A, Sergeant G, Ectors N, et al. (2009) Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 35:600–604 Van den Broeck A, Sergeant G, Ectors N, et al. (2009) Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 35:600–604
12.
go back to reference Witkowski ER, Smith JK, Ragulin-Coyne E, et al. (2012) Is it worth looking? Abdominal imaging after pancreatic cancer resection: a national study. J Gastrointest Surg Off J Soc Surg Aliment Tract 16:121–128CrossRef Witkowski ER, Smith JK, Ragulin-Coyne E, et al. (2012) Is it worth looking? Abdominal imaging after pancreatic cancer resection: a national study. J Gastrointest Surg Off J Soc Surg Aliment Tract 16:121–128CrossRef
13.
go back to reference Sheffield KM, Crowell KT, Lin Y-L, et al. (2012) Surveillance of pancreatic cancer patients after surgical resection. Ann Surg Oncol 19:1670–1677CrossRefPubMed Sheffield KM, Crowell KT, Lin Y-L, et al. (2012) Surveillance of pancreatic cancer patients after surgical resection. Ann Surg Oncol 19:1670–1677CrossRefPubMed
14.
go back to reference Castellanos JA, Merchant NB (2014) Intensity of follow-up after pancreatic cancer resection. Ann Surg Oncol 21:747–751CrossRefPubMed Castellanos JA, Merchant NB (2014) Intensity of follow-up after pancreatic cancer resection. Ann Surg Oncol 21:747–751CrossRefPubMed
15.
go back to reference Nordby T, Hugenschmidt H, Fagerland MW, et al. (2013) Follow-up after curative surgery for pancreatic ductal adenocarcinoma: asymptomatic recurrence is associated with improved survival. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 39:559–566 Nordby T, Hugenschmidt H, Fagerland MW, et al. (2013) Follow-up after curative surgery for pancreatic ductal adenocarcinoma: asymptomatic recurrence is associated with improved survival. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 39:559–566
16.
17.
go back to reference Vincent A, Herman J, Schulick R, Hruban RH, Goggins M (2011) Pancreatic cancer. Lancet Lond Engl 378:607–620CrossRef Vincent A, Herman J, Schulick R, Hruban RH, Goggins M (2011) Pancreatic cancer. Lancet Lond Engl 378:607–620CrossRef
18.
go back to reference Liao W-C, Chien K-L, Lin Y-L, et al. (2013) Adjuvant treatments for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis. Lancet Oncol 14:1095–1103CrossRefPubMed Liao W-C, Chien K-L, Lin Y-L, et al. (2013) Adjuvant treatments for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis. Lancet Oncol 14:1095–1103CrossRefPubMed
19.
go back to reference Han S-S, Jang J-Y, Kim S-W, et al. (2006) Analysis of long-term survivors after surgical resection for pancreatic cancer. Pancreas 32:271–275CrossRefPubMed Han S-S, Jang J-Y, Kim S-W, et al. (2006) Analysis of long-term survivors after surgical resection for pancreatic cancer. Pancreas 32:271–275CrossRefPubMed
20.
go back to reference Rau BM, Moritz K, Schuschan S, et al. (2012) R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use. Surgery 152:S103–S111CrossRefPubMed Rau BM, Moritz K, Schuschan S, et al. (2012) R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use. Surgery 152:S103–S111CrossRefPubMed
21.
go back to reference Konstantinidis IT, Warshaw AL, Allen JN, et al. (2013) Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a “true” R0 resection? Ann Surg 257:731–736CrossRefPubMed Konstantinidis IT, Warshaw AL, Allen JN, et al. (2013) Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a “true” R0 resection? Ann Surg 257:731–736CrossRefPubMed
22.
go back to reference Laurence JM, Tran PD, Morarji K, et al. (2011) A systematic review and meta-analysis of survival and surgical outcomes following neoadjuvant chemoradiotherapy for pancreatic cancer. J Gastrointest Surg Off J Soc Surg Aliment Tract 15:2059–2069CrossRef Laurence JM, Tran PD, Morarji K, et al. (2011) A systematic review and meta-analysis of survival and surgical outcomes following neoadjuvant chemoradiotherapy for pancreatic cancer. J Gastrointest Surg Off J Soc Surg Aliment Tract 15:2059–2069CrossRef
23.
go back to reference Colbert LE, Hall WA, Nickleach D, et al. (2014) Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base. Cancer 120:499–506CrossRefPubMedPubMedCentral Colbert LE, Hall WA, Nickleach D, et al. (2014) Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base. Cancer 120:499–506CrossRefPubMedPubMedCentral
Metadata
Title
Post-Whipple imaging in patients with pancreatic ductal adenocarcinoma: association with overall survival: a multivariate analysis
Authors
Azadeh Elmi
Janet Murphy
Sandeep Hedgire
Shaunagh McDermott
Seyed-Mahdi Abtahi
Elkan Halpern
Carlos Fernandez-del Castillo
Mukesh Harisinghani
Publication date
01-08-2017
Publisher
Springer US
Published in
Abdominal Radiology / Issue 8/2017
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-017-1099-2

Other articles of this Issue 8/2017

Abdominal Radiology 8/2017 Go to the issue

Classics in Abdominal Imaging

Snowstorm testes

Classics in Abdominal Imaging

The “polka-dot” sign

Classics in Abdominal Imaging

The “stipple sign”

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.